These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 8159669)
21. Purification, crystallization, X-ray diffraction analysis and phasing of a Fab fragment of monoclonal neuroantibody alphaD11 against nerve growth factor. Covaceuszach S; Cassetta A; Cattaneo A; Lamba D Acta Crystallogr D Biol Crystallogr; 2004 Jul; 60(Pt 7):1323-7. PubMed ID: 15213405 [TBL] [Abstract][Full Text] [Related]
22. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches. de Prat-Gay G Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027 [TBL] [Abstract][Full Text] [Related]
23. Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona. Gomes P; Giralt E; Andreu D Vaccine; 2001 May; 19(25-26):3459-66. PubMed ID: 11348711 [TBL] [Abstract][Full Text] [Related]
24. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Parry N; Fox G; Rowlands D; Brown F; Fry E; Acharya R; Logan D; Stuart D Nature; 1990 Oct; 347(6293):569-72. PubMed ID: 1699132 [TBL] [Abstract][Full Text] [Related]
25. A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation. Verdaguer N; Sevilla N; Valero ML; Stuart D; Brocchi E; Andreu D; Giralt E; Domingo E; Mateu MG; Fita I J Virol; 1998 Jan; 72(1):739-48. PubMed ID: 9420281 [TBL] [Abstract][Full Text] [Related]
27. Use of streptococcal protein G in obtaining crystals of an antibody Fab fragment in complex with a meningococcal antigen. Derrick JP; Feavers I; Maiden MC Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):314-6. PubMed ID: 10089436 [TBL] [Abstract][Full Text] [Related]
28. Crystallization and preliminary X-ray data for the human transthyretin-retinol-binding protein (RBP) complex bound to an anti-RBP Fab. Malpeli G; Zanotti G; Gliubich F; Rizzotto A; Nishida SK; Folli C; Berni R Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):276-8. PubMed ID: 10089423 [TBL] [Abstract][Full Text] [Related]
29. Crystallization and preliminary X-ray diffraction studies of complexes between an influenza hemagglutinin and Fab fragments of two different monoclonal antibodies. Gigant B; Fleury D; Bizebard T; Skehel JJ; Knossow M Proteins; 1995 Sep; 23(1):115-7. PubMed ID: 8539243 [TBL] [Abstract][Full Text] [Related]
30. Crystallization and preliminary X-ray diffraction studies of a bacterial flavohemoglobin protein. Ermler U; Siddiqui RA; Cramm R; Schröder D; Friedrich B Proteins; 1995 Apr; 21(4):351-3. PubMed ID: 7567956 [TBL] [Abstract][Full Text] [Related]
31. Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding. Feliu JX; Benito A; Oliva B; Avilés FX; Villaverde A J Mol Biol; 1998 Oct; 283(2):331-8. PubMed ID: 9769208 [TBL] [Abstract][Full Text] [Related]
32. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2. Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980 [TBL] [Abstract][Full Text] [Related]
33. Crystallization and preliminary crystallographic analysis of the N-terminal two domain fragment of vascular cell adhesion molecule-1 (VCAM-1). Wang J; Pepinsky B; Karpusas M; Liu J; Osborn L Proteins; 1994 Nov; 20(3):287-90. PubMed ID: 7534402 [TBL] [Abstract][Full Text] [Related]
34. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates). Tulasiram P; Suryanarayana V Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655 [TBL] [Abstract][Full Text] [Related]
35. Crystallization of the Fab from a human monoclonal antibody against gp 41 of human immunodeficiency virus type I. Casale E; Wenisch E; He XM; Righetti PG; Snyder RS; Jungbauer A; Tauer C; Ruker F; Carter DC J Mol Biol; 1990 Dec; 216(3):511-2. PubMed ID: 2258926 [TBL] [Abstract][Full Text] [Related]
37. Crystallization and preliminary X-ray diffraction studies of the Lb proteinase from foot-and-mouth disease virus. Guarné A; Kirchweger R; Verdaguer N; Liebig HD; Blaas D; Skern T; Fita I Protein Sci; 1996 Sep; 5(9):1931-3. PubMed ID: 8880919 [TBL] [Abstract][Full Text] [Related]
38. Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals. Winther MD; Allen G; Bomford RH; Brown F J Immunol; 1986 Mar; 136(5):1835-40. PubMed ID: 3005401 [TBL] [Abstract][Full Text] [Related]
39. Docking of a human rhinovirus neutralizing antibody onto the viral capsid. Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845 [TBL] [Abstract][Full Text] [Related]
40. Characterization of crystals of an Fab fragment of a murine monoclonal antibody. Ban N; Escobar C; Day J; Greenwood A; Larson S; McPherson A J Mol Biol; 1991 Dec; 222(3):445-6. PubMed ID: 1660922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]